ecancer

The Cancer Genome Atlas (TCGA)

Dr Paul Spellman - National Cancer Institute, Bethesda, USA

21 Apr 2011

Combination therapy targeting MEK and PI3K pathways shows anti-tumour activity

Dr Johanna Bendell - Sarah Cannon Research Institute, Nashville, USA

20 Apr 2011

Ethical considerations surrounding cancer in the elderly and the pros and cons of web-based resources

Ian Banks (European Men's Health Forum), Jan Geissler (Leukamie-Online), Ellen Verschuur (Europa Donna)

17 Mar 2011

Treatment of brain metastases in melanoma patients

Dr Caroline Robert - Institute Gustave Roussy, Paris, France; Prof Alexander Eggermont - Erasmus University of Rotterdam, Netherlands

7 Feb 2011

Sarah Cannon Research Institute research developments at ASCO 2010

Dr Howard Burris, The Sarah Cannon Research Institute, Nashville

4 Feb 2011

Clinical benefits and side effects of ipilimumab in melanoma patients

Prof. Giorgio Parmiani - Fondazione San Raffaele del Monte Tabor, Milan, Italy

31 Jan 2011

Molecular chaperones: cancer dependence and druggability

Prof Paul Workman - The Institute of Cancer Research, Sutton, UK

19 Jan 2011

World Health Organisation cancer prevention and control

Dr Andreas Ullrich - World Health Organisation Medical Officer

21 Dec 2010

The European Academy of Cancer Sciences

Prof Alexander Eggermont and Prof Anton Berns

21 Dec 2010

ESTRO 2010 - Snapshots from the conference

European Society for Therapeutic Radiology and Oncology meeting, Barcelona, 12-16th September 2010

25 Oct 2010

ESTRO 2010 Highlights

Professor Gordon McVie - European Institute of Oncology

6 Oct 2010

The role of the B-RAF mutation in melanoma treatment

Prof Richard Marais - Institute of Cancer Research, London, UK

17 Aug 2010

More from ecancer